| MDR | median duration of response; medical device reporting; minimum daily requirement; multidrug resistan... |
|---|---|
| MDR | TB multidrug-resistant tuberculosis |
| MRP | mean resisting potential; medical reimbursement plan; multidrug resistance-associated protein |
| GLUT | glucose transporter |
| NET | nasoendotracheal tube; nerve excitability test; neuroectodermal tumor; neuroendocrine tumor; norepin... |
| MRP | Multidrug Resistance Protein |
|---|---|
| MRP1 | Multidrug Resistance Protein 1 |
| MRP | Multidrug Resistance associated Protein |
| MDR 1 | Multidrug Resistance gene |
| MRP(1) | Multidrug Resistance-Associated protein |
| multidrug transporter | Closely related family (ABC transporters) of integral membrane glycoproteins that export a variety of solutes from the cytoplasm. (18 Nov 1997) |
|---|
| transporter | Proteins that go completely through a cell membrane and carry specific nutrients, ions, etc. Across the membrane. (09 Oct 1997) |
|---|---|
| multidrug resistance | The insensitivity of various tumours to a variety of chemically related anticancer drugs; mediated by a process of inactivating the drug or removing it from the target tumour cells. (05 Mar 2000) |
| tuberculosis, multidrug-resistant | Tuberculosis resistant to chemotherapy with two or more antitubercular agents. The problem of resistance is particularly troublesome in tuberculosis as an opportunistic disease in HIV infection. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|